Skip to main content

Atherosclerosis Plus

  • ISSN: 2667-0895

Next planned ship date: June 19, 2024

  • 5 Year impact factor: 1.6
  • Impact factor: 1.6

Previously published as Atherosclerosis Supplements. Atherosclerosis Plus is supported by the European Atherosclerosis Society.Atherosclerosis Plus publishes both original r… Read more

Subscription options

Next planned ship date:
June 19, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Previously published as Atherosclerosis Supplements.

Atherosclerosis Plus is supported by the European Atherosclerosis Society.

Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions. Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. Finally, the journal periodically publishes special theme issues devoted to areas of current interest.